Johan Sjodahl
Director Técnico/Científico/I+D en ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) .
Perfil
Johan Sjodahl is currently the Chief Scientific Officer at ISR Immune System Regulation Holding AB since 2021.
He has a graduate and doctorate degree from the Royal Institute of Technology.
Cargos activos de Johan Sjodahl
| Empresas | Cargo | Inicio |
|---|---|---|
| ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) | Director Técnico/Científico/I+D | 01/01/2021 |
Formación de Johan Sjodahl.
| Royal Institute of Technology | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
ISR Immune System Regulation Holding AB
 ISR Immune System Regulation Holding AB Pharmaceuticals: MajorHealth Technology ISR Immune System Regulation Holding AB engages in pharmaceutical research for the treatment of viral diseases focusing on Human Immunodeficiency Virus (HIV). It is developing ISR048 for the novel treatment of HIV. The company was founded by Yen Lundgren and Ulf Ljungblad in September 17, 2015 and is headquartered in Solna, Sweden. | Health Technology |
- Bolsa de valores
- Insiders
- Johan Sjodahl
